Aluminum phthalocyanine tetrasulfonate conjugated to surface-modified Iron oxide nanoparticles as a magnetic targeting platform for photodynamic therapy of Ehrlich tumor-bearing mice.
Autor: | Fauiod OG; Pharmaceutical Nanotechnology Unit, Department of Medical Applications of Laser, National Institute of Laser Enhanced Sciences, Cairo University, Egypt., Fadel M; Pharmaceutical Nanotechnology Unit, Department of Medical Applications of Laser, National Institute of Laser Enhanced Sciences, Cairo University, Egypt., El-Hussein A; Laser Applications in Metrology, Photochemistry and Agriculture unit, National Institute of Laser Enhanced Sciences, Cairo University, Giza, Egypt; Faculty of Science, Galala University, Egypt., Fadeel DA; Pharmaceutical Nanotechnology Unit, Department of Medical Applications of Laser, National Institute of Laser Enhanced Sciences, Cairo University, Egypt. Electronic address: d_fadeel@cu.edu.eg. |
---|---|
Jazyk: | angličtina |
Zdroj: | Photodiagnosis and photodynamic therapy [Photodiagnosis Photodyn Ther] 2024 Dec; Vol. 50, pp. 104356. Date of Electronic Publication: 2024 Oct 04. |
DOI: | 10.1016/j.pdpdt.2024.104356 |
Abstrakt: | Background: Photodynamic therapy (PDT) is a targeted treatment option for cancers that are non-responding to ordinary anticancer therapies. It involves activating a photosensitizer with a light source of a specific wavelength to destroy targeted cells and their surrounding vasculature. Aluminum phthalocyanine tetra sulfonate (AlPcS Methods: Magnetic glutamine functionalized iron oxide nanocomposites loaded with AlPcS Results: AlPcS Conclusion: PDT mediated by magnetic targeting significantly inhibited tumor growth with minimal adverse effects, indicating its great potential as a promising strategy for solid cancer treatment. Competing Interests: Declaration of competing interest The authors declare no competing interests. (Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |